Combinatorial Targeting of ATF5 and the PI3K/mTOR Signaling Pathway as a Therapeutic Strategy for Glioblastoma

被引：0
|
作者：
Chau, Lily
Karpel-Massler, Georg
Shu, Chang
Angelastro, James
Greene, Lloyd
Siegelin, Markus
机构：
[1] Columbia Univ, New York, NY USA
[2] UC Davis Sch Vet Med, Davis, CA USA
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1716
引用
收藏
页码：429A / 430A
页数：2
相关论文
共 50 条
  • [31] THE PI3K/MTOR PATHWAY CONTRIBUTES TO SEX DIFFERENCES IN GLIOBLASTOMA
    Sponagel, Jasmin
    Yu, Kwanha
    Ippolito, Joseph
    Deneen, Benjamin
    Rubin, Josh
    NEURO-ONCOLOGY, 2018, 20 : 90 - 90
  • [32] Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy
    Tewari, Devesh
    Patni, Pooja
    Bishayee, Anusha
    Sah, Archana N.
    Bishayee, Anupam
    SEMINARS IN CANCER BIOLOGY, 2022, 80 : 1 - 17
  • [33] Targeting the PI3K/mTOR pathway in idiopathic pulmonary fibrosis: Advances and therapeutic potential
    Wang, Zhengyang
    Guo, Yanzhi
    Li, Kaiyin
    Huo, Yan
    Wang, Shuyan
    Dong, Suzhen
    Ma, Mingliang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 115
  • [34] Targeting PI3K/Akt/mTOR signaling pathway by polyphenols: Implication for cancer therapy
    Mirza-Aghazade, Mohammad
    Ekrami, Elyad Mohammadi
    Aghdas, Seyyed Ali Mousavi
    Mihanfar, Ainaz
    Hallaj, Shahin
    Yousefi, Bahman
    Safa, Amin
    Majidinia, Maryam
    LIFE SCIENCES, 2020, 255
  • [35] Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance
    Chang, Lei
    Graham, Peter H.
    Ni, Jie
    Hao, Jingli
    Bucci, Joseph
    Cozzi, Paul J.
    Li, Yong
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (03) : 507 - 517
  • [36] Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia
    Roccaro, Aldo M.
    Sacco, Antonio
    Husu, Emanuel N.
    Pitsillides, Costas
    Vesole, Steven
    Azab, Abdel Kareem
    Azab, Feda
    Melhem, Molly
    Ngo, Hai T.
    Quang, Phong
    Maiso, Patricia
    Runnels, Judith
    Liang, Mei-Chih
    Wong, Kwok-Kin
    Lin, Charles
    Ghobrial, Irene M.
    BLOOD, 2010, 115 (03) : 559 - 569
  • [37] Targeting PI3K/mTOR/MAPK pathway in inhibition of cell growth and dissemination of glioblastoma multiforme
    Shannon, Craig M.
    Mohan, Avinash
    Braun, Alex
    Murali, Raj
    Jhanwar-Uniyal, Meena
    CANCER RESEARCH, 2011, 71
  • [38] Targeting PI3K signaling is a potential therapeutic strategy in Clear Cell Sarcoma
    Leuenberger, L. P.
    Isenegger, L.
    Zaninotto, E.
    Pauli, C.
    Bode, P. K.
    Camenisch, U.
    Matter, C.
    Moch, H.
    Britschgi, C.
    SWISS MEDICAL WEEKLY, 2022, 152 : 32S - 32S
  • [39] Tenacissoside H repressed the progression of glioblastoma by inhibiting the PI3K/Akt/mTOR signaling pathway
    Dong, Jianhong
    Qian, Yiming
    Zhang, Wei
    Xu, Jiayun
    Wang, Lipei
    Fan, Ziwei
    Jia, Mengxian
    Wei, Lijia
    Yang, Hui
    Luo, Xuan
    Wang, Yongjie
    Jiang, Yuanyuan
    Huang, Zhihui
    Wang, Ying
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 968
  • [40] Targeting the PI3K/Akt/mTOR Pathway in Ocular Neovascularization
    Sasore, Temitope
    Reynolds, Alison L.
    Kennedy, Breandan N.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2014, 801 : 805 - 811
12345